-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • Kala Bio (NASDAQ:KALA) shares increased by 7.2% to $0.13 during Monday's after-market session. The market value of their outstanding shares is at $126.5 million.
  • Prothena Corp (NASDAQ:PRTA) stock rose 6.39% to $11.48. The company's market cap stands at $578.7 million.
  • Revolution Medicines (NASDAQ:RVMD) stock moved upwards by 6.32% to $140.0. The company's market cap stands at $28.6 billion.
  • BioAtla (NASDAQ:BCAB) shares increased by 6.2% to $4.79. The market value of their outstanding shares is at $8.0 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) shares rose 6.05% to $1.22. The market value of their outstanding shares is at $33.5 million.
  • Trevi Therapeutics (NASDAQ:TRVI) shares moved upwards by 4.55% to $14.92. The market value of their outstanding shares is at $2.0 billion.

Losers

  • Erasca (NASDAQ:ERAS) stock declined by 25.0% to $14.37 during Monday's after-market session. The company's market cap stands at $6.6 billion.
  • Advanced Biomed (NASDAQ:ADVB) shares decreased by 6.9% to $5.0. The company's market cap stands at $7.8 million.
  • EUDA Health Holdings (NASDAQ:EUDA) stock decreased by 5.99% to $12.09. The company's market cap stands at $26.7 million.
  • iTonic Holdings (NASDAQ:ITOC) shares declined by 5.68% to $0.38. The company's market cap stands at $6.3 million.
  • Aspire Biopharma Holdings (NASDAQ:ASBP) shares fell 5.43% to $0.23. The company's market cap stands at $1.0 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) shares decreased by 5.02% to $0.57. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending